Your browser is no longer supported. Please, upgrade your browser.
Settings
CBPO China Biologic Products Holdings, Inc. daily Stock Chart
CBPO [NASD]
China Biologic Products Holdings, Inc.
Index- P/E34.96 EPS (ttm)2.31 Insider Own26.43% Shs Outstand33.15M Perf Week2.17%
Market Cap2.68B Forward P/E15.66 EPS next Y5.17 Insider Trans0.00% Shs Float24.43M Perf Month-3.59%
Income- PEG8.94 EPS next Q1.15 Inst Own58.50% Short Float6.49% Perf Quarter-3.40%
Sales391.50M P/S6.85 EPS this Y2.80% Inst Trans-2.22% Short Ratio6.46 Perf Half Y-4.79%
Book/sh33.25 P/B2.43 EPS next Y9.59% ROA- Target Price104.24 Perf Year-28.50%
Cash/sh6.78 P/C11.93 EPS next 5Y3.91% ROE- 52W Range71.85 - 116.73 Perf YTD2.67%
Dividend- P/FCF37.23 EPS past 5Y18.00% ROI18.70% 52W High-32.34% Beta1.43
Dividend %- Quick Ratio4.50 Sales past 5Y14.90% Gross Margin67.60% 52W Low9.93% ATR2.75
Employees1912 Current Ratio6.50 Sales Q/Q23.00% Oper. Margin- RSI (14)40.73 Volatility3.30% 3.37%
OptionableYes Debt/Eq0.00 EPS Q/Q5.30% Profit Margin- Rel Volume1.63 Prev Close80.87
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout0.00% Avg Volume245.41K Price78.98
Recom1.90 SMA20-5.00% SMA50-5.55% SMA200-6.40% Volume219,849 Change-2.34%
May-14-18Downgrade Jefferies Buy → Hold
May-30-17Initiated Goldman Neutral
Mar-01-16Downgrade Credit Suisse Outperform → Neutral
Oct-08-15Initiated Credit Suisse Outperform
Jul-09-15Initiated BofA/Merrill Buy $135
Jul-08-14Reiterated Aegis Capital Buy $50 → $55
Mar-14-14Initiated Oppenheimer Outperform $46
Nov-06-13Downgrade Aegis Capital Buy → Hold
Mar-14-13Reiterated Aegis Capital Buy $22 → $28
May-13-10Reiterated Brean Murray Buy $19 → $20
Mar-26-10Reiterated Brean Murray Buy $15 → $19
May-08-18 07:00AM  Blog Exposure - Portola Pharma Receives Approval from FDA for Its Lead Candidate ACCESSWIRE
May-04-18 04:37PM  China Biologic Products: 1Q Earnings Snapshot Associated Press
04:30PM  China Biologic Reports Financial Results for the First Quarter of 2018 PR Newswire
Apr-30-18 11:06AM  Is There An Opportunity With China Biologic Products Holdings Incs (NASDAQ:CBPO) 39% Undervaluation? Simply Wall St.
Apr-27-18 02:34PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Got Enough Cash? Simply Wall St.
Apr-13-18 07:45AM  Investor Expectations to Drive Momentum within Criteo S.A, Prima BioMed, CoStar Group, DBV Technologies S.A, Hollysys Automation Technologies, and China Biologic Products Discovering Underlying Factors of Influence GlobeNewswire
Mar-16-18 08:15AM  Recent Analysis Shows Clementia Pharmaceuticals, MyoKardia, Landec, Sapiens International Corporation N.V, AppFolio, and China Biologic Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-28-18 05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2017 PR Newswire
Feb-23-18 08:00AM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2017 Financial Results PR Newswire
Feb-14-18 08:30AM  China Biologic to Build New Collection Station in Hainan Province PR Newswire
Feb-09-18 12:52PM  Should You Expect China Biologic Products Holdings Inc (NASDAQ:CBPO) To Continue Delivering An ROE Of 20.70%? Simply Wall St.
Jan-08-18 04:32PM  Has China Biologic Products Holdings Inc (NASDAQ:CBPO) Improved Earnings Growth In Recent Times? Simply Wall St.
08:00AM  China Biologic to Attend the 36th Annual J.P. Morgan Healthcare Conference PR Newswire
08:00AM  China Biologic Announces Corporate Update PR Newswire
Jan-03-18 08:06AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
06:00AM  China Biologic Announces Completion of Acquisition of TianXinFu from PWM PR Newswire
Jan-01-18 01:55PM  How Do Analysts See China Biologic Products Holdings Inc (NASDAQ:CBPO) Performing Over The Next Few Years? Simply Wall St.
Dec-29-17 12:52PM  China Biologic Products Holdings, Inc. Value Analysis (NASDAQ:CBPO) : December 29, 2017 Capital Cube
Dec-28-17 07:20AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : December 28, 2017 Capital Cube
Dec-22-17 03:55PM  Should You Be Tempted To Buy China Biologic Products Holdings Inc (NASDAQ:CBPO) Because Of Its PE Ratio? Simply Wall St.
Dec-15-17 08:30AM  China Biologic Receives Operating Permit for New Collection Facility in Ju County in Shandong Province PR Newswire
Dec-07-17 02:03PM  Has China Biologic Products Holdings Inc (CBPO) Got Enough Cash To Cover Its Short-Term Obligations? Simply Wall St.
Dec-04-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-22-17 08:20PM  What Do Analysts Think About China Biologic Products Holdings Incs (CBPO) Growth? Simply Wall St.
Nov-21-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-20-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-15-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-14-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Nov-08-17 03:59PM  Calculating The Intrinsic Value Of China Biologic Products Holdings Inc (CBPO) Simply Wall St.
Nov-07-17 09:52AM  ETFs with exposure to China Biologic Products Holdings, Inc. : November 7, 2017 Capital Cube
Nov-02-17 05:47AM  China Biologic Products posts 3Q profit Associated Press
Nov-01-17 04:30PM  China Biologic Reports Unaudited Financial Results for the Third Quarter of 2017 PR Newswire
Oct-27-17 10:48AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 27, 2017 Capital Cube
Oct-26-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Oct-25-17 08:00AM  China Biologic Products to Report Third Quarter of 2017 Financial Results PR Newswire
Oct-13-17 10:36AM  ETFs with exposure to China Biologic Products Holdings, Inc. : October 13, 2017 Capital Cube
08:36AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 13, 2017 Capital Cube
08:00AM  China Biologic Products Announces Conference Call to Discuss TianXinFu Acquisition PR Newswire
Oct-12-17 08:30AM  China Biologic Agrees to Acquire TianXinFu from PWM PR Newswire -14.99%
Oct-09-17 08:30AM  China Biologic Receives Approval for Commercial Manufacturing of Human Fibrinogen PR Newswire
Oct-03-17 08:16AM  China Biologic Products Holdings, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : October 3, 2017 Capital Cube
Sep-28-17 10:10AM  ETFs with exposure to China Biologic Products Holdings, Inc. : September 28, 2017 Capital Cube
Sep-27-17 09:04AM  China Biologic Products Holdings, Inc. :CBPO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 27, 2017 Capital Cube
Sep-12-17 08:07AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-11-17 10:11AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-08-17 10:26AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Sep-01-17 08:02AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-31-17 08:08AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit +7.17%
Aug-30-17 08:03AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-12-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-10-17 08:05AM  See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc. Markit
Aug-09-17 08:05AM  IHS Markit Score upgrades China Biologic Products Holdings Inc to 34 out of 100, despite ranking positively in only one IHS Markit category. Markit
07:00AM  Featured Company News MannKind and One Drop Announce Collaboration to Deliver a Unified Solution for Diabetes Patients ACCESSWIRE
Aug-04-17 02:36AM  China Biologic Products posts 2Q profit Associated Press
Aug-03-17 05:00AM  Investor Network: China Biologic Products, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-17 05:00PM  China Biologic Reports Financial Results for the Second Quarter of 2017 PR Newswire
Jul-25-17 03:44AM  Why China Biologic is the Best of China's Blood Plasma Stocks Barrons.com
Jul-24-17 05:50AM  Edited Transcript of CBPO earnings conference call or presentation 5-Aug-16 11:30am GMT Thomson Reuters StreetEvents
05:50AM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
05:49AM  Edited Transcript of CBPO earnings conference call or presentation 7-May-15 11:30am GMT Thomson Reuters StreetEvents
Jul-19-17 08:00AM  China Biologic Products to Report Second Quarter of 2017 Financial Results PR Newswire
Jul-17-17 01:40PM  ETFs with exposure to China Biologic Products, Inc. : July 17, 2017 Capital Cube
Jul-06-17 01:47PM  ETFs with exposure to China Biologic Products, Inc. : July 6, 2017 Capital Cube
Jul-04-17 09:53AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : July 4, 2017 Capital Cube
Jun-22-17 03:29PM  ETFs with exposure to China Biologic Products, Inc. : June 22, 2017 Capital Cube
Jun-16-17 11:46AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-09-17 02:12PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : June 9, 2017 Capital Cube
Jun-08-17 08:24AM  China Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : June 8, 2017 Capital Cube -5.88%
May-19-17 04:05PM  China Biologic Announces Effectiveness of Registration Statement and Mailing of Definitive Proxy Statement/Prospectus for 2017 Annual Meeting of Stockholders PR Newswire
May-08-17 09:27AM  Edited Transcript of CBPO earnings conference call or presentation 4-May-17 11:30am GMT Thomson Reuters StreetEvents
May-04-17 10:29PM  This Chinese Pharma Stock Has 20% Upside Barrons.com
07:05AM  Investor Network: China Biologic Products, Inc. to Host Earnings Call Accesswire
05:02AM  China Biologic Products posts 1Q profit Associated Press
May-03-17 04:45PM  China Biologic Reports Financial Results for the First Quarter of 2017 PR Newswire
Apr-21-17 08:00AM  China Biologic Products to Report First Quarter of 2017 Financial Results PR Newswire
Apr-12-17 01:21PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : April 12, 2017 Capital Cube
Apr-11-17 08:17AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : April 11, 2017 Capital Cube
Apr-07-17 04:05PM  ETFs with exposure to China Biologic Products, Inc. : April 7, 2017 Capital Cube
Mar-02-17 10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Capital Cube
10:06AM  China Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 01:04PM  CHINA BIOLOGIC PRODUCTS, INC. Financials
Feb-24-17 01:22PM  Edited Transcript of CBPO earnings conference call or presentation 24-Feb-17 12:30pm GMT Thomson Reuters StreetEvents
Feb-23-17 07:53PM  China Biologic Products posts 4Q profit Associated Press
05:00PM  China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2016 PR Newswire
04:57PM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-K, Annual Report
07:07AM  Q4 2016 China Biologic Products Inc Earnings Release - After Market Close
Feb-14-17 04:05PM  China Biologic Products to Report Fourth Quarter and Fiscal Year 2016 Financial Results PR Newswire
Jan-30-17 09:20AM  New Strong Sell Stocks for January 30th Zacks
Jan-27-17 01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017 Capital Cube
01:34PM  China Biologic Products, Inc. Value Analysis (NASDAQ:CBPO) : January 27, 2017
Jan-26-17 07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017 Capital Cube
07:52AM  China Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : January 26, 2017
Jan-18-17 08:01AM  New Strong Sell Stocks for January 18th
Jan-06-17 08:46AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  China Biologic to Build New Collection Station and New Branch Collection Facility in Shandong Province PR Newswire
Jan-04-17 08:47AM  CHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
08:30AM  China Biologic to Attend the 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-01-17 07:22AM  3 Biotech Stocks That Turned $10,000 Into Over $100,000 at Motley Fool
Dec-14-16 12:49PM  ETFs with exposure to China Biologic Products, Inc. : December 14, 2016
Dec-01-16 01:16PM  Should You Follow Hedge Funds Into China Biologic Products Inc (CBPO)? at Insider Monkey -5.12%
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin for intravenous injection products for original and secondary immunoglobulin deficiency, and auto-immune deficiency diseases; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing immune globulin intravenous; human antithrombin III; Caprylate/Chromatography Purified and 20 nm virus filtration; human coagulation factor IX; human cytomegalovirus immunoglobulin; and human fibrin sealant products. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.